Leiden University is joining a new European initiative that aims to better connect and strengthen cancer research. By pooling knowledge and data from different countries, the initiative is working to achieve faster diagnoses and more effective treatments.
IBL researcher Lennart Schada von Borzyskowski receives EU funding for C5, a project that uses cyanobacteria to convert sunlight, CO₂ and water into sustainable fuels. The Solar-to-X technology will be launched in 2025 and promotes the European Green Deal
NWO has awarded eighteen promising researchers from Leiden University a prestigious Veni grant. This grant will enable them to further develop their own innovative research projects over the next three years and carry them out independently.
Researchers at Leiden University Medical Center (LUMC) have made an important step forward in brain imaging. With a new technique, they can now visualise even the tiniest blood vessels in the brain.
A new experimental vaccine developed in Leiden targets lung cancer cells that evade the immune system. The approach could make immunotherapy more effective for patients for whom existing treatments prove ineffective.
Two research teams from Leiden University have been awarded HTSM funding for groundbreaking technological research with applications in areas such as quality control and medical imaging.